Cargando…
Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003–2017)
PURPOSE: Screen-detected unilateral non-palpable breast cancer (NPBC) shows favorable prognosis, whereas bilateral breast cancer (BBC), especially synchronous BBC (SBBC) manifests worse survival than unilateral breast cancer (BC). It remains unclear whether screen-detected bilateral NPBC has comprom...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581860/ https://www.ncbi.nlm.nih.gov/pubmed/36166112 http://dx.doi.org/10.1007/s10549-022-06747-5 |
_version_ | 1784812722867666944 |
---|---|
author | Pan, Bo Xu, Ying Zhou, Yidong Yao, Ru Zhou, Xingtong Xu, Yali Ren, Xinyu Xiao, Mengsu Zhu, Qingli Kong, Lingyan Mao, Feng Lin, Yan Zhang, Xiaohui Shen, Songjie Sun, Qiang |
author_facet | Pan, Bo Xu, Ying Zhou, Yidong Yao, Ru Zhou, Xingtong Xu, Yali Ren, Xinyu Xiao, Mengsu Zhu, Qingli Kong, Lingyan Mao, Feng Lin, Yan Zhang, Xiaohui Shen, Songjie Sun, Qiang |
author_sort | Pan, Bo |
collection | PubMed |
description | PURPOSE: Screen-detected unilateral non-palpable breast cancer (NPBC) shows favorable prognosis, whereas bilateral breast cancer (BBC), especially synchronous BBC (SBBC) manifests worse survival than unilateral breast cancer (BC). It remains unclear whether screen-detected bilateral NPBC has compromised survival and requires intensified treatment or favorable prognosis and needs de-escalating therapy. METHODS: From 2003 to 2017, 1,075 consecutive NPBC patients were retrospectively reviewed. There were 988 patients with unilateral NPBC (UniNPBC), and 87 patients with ipsilateral NPBC + any contralateral BC [(N + AnyContra) PBC], including 32 patients with bilateral NPBC (BiNPBC) and 55 patients with ipsilateral NPBC + contralateral palpable cancer [(N + Contra) PBC]. Median follow-up time was 91 (48–227) months. Clinicopathological characteristics were compared between UniNPBC and BBC, whereas relapse-free survival (RFS) and overall survival (OS) among BBC subgroups. RFS and OS factors of BBC were identified. RESULTS: Compared to UniNPBC, patients with screen-detected bilateral BC had more invasive (85.1%, 74.8%), ER negative (26.4%, 17.1%), PR negative (36.8%, 23.5%), triple-negative (21.6%, 8.5%) BC as well as less breast conserving surgery (17.2%, 32.4%), radiotherapy (13.8%, 32.0%) and endocrine therapy (71.3%, 83.9%). 10 year RFS and OS rates of (N + AnyContra) PBC (72.8%, 81.5%), (N + Contra) PBC (60.6%, 73.9%), and synchronous (N + Contra) PBC (58.1%, 70.1%) were significantly compromised compared to UniNPBC (91.0%, 97.2%). RFS factors of BBC included pN3 (p = 0.048), lymphovascular invasion (p = 0.008) and existence of contralateral palpable interval BC (p = 0.008), while the OS relevant factor was pN3 (p = 0.018). CONCLUSION: Screen-detected bilateral NPBC including SynBiNPBC and MetaBiNPBC showed good prognosis as UniNPBC so that the therapy of BiNPBC could be de-escalated and optimized according to UniNPBC. Contrarily, screen-detected ipsilateral NPBC with contralateral palpable BC [(N + Contra) PBC] manifested unfavorable survival worse than UniNPBC and synchronous (N + Contra) PBC had the worst survival among all subgroups, implying that these were actually bilateral interval BC and required intensified treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10549-022-06747-5. |
format | Online Article Text |
id | pubmed-9581860 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-95818602022-10-21 Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003–2017) Pan, Bo Xu, Ying Zhou, Yidong Yao, Ru Zhou, Xingtong Xu, Yali Ren, Xinyu Xiao, Mengsu Zhu, Qingli Kong, Lingyan Mao, Feng Lin, Yan Zhang, Xiaohui Shen, Songjie Sun, Qiang Breast Cancer Res Treat Epidemiology PURPOSE: Screen-detected unilateral non-palpable breast cancer (NPBC) shows favorable prognosis, whereas bilateral breast cancer (BBC), especially synchronous BBC (SBBC) manifests worse survival than unilateral breast cancer (BC). It remains unclear whether screen-detected bilateral NPBC has compromised survival and requires intensified treatment or favorable prognosis and needs de-escalating therapy. METHODS: From 2003 to 2017, 1,075 consecutive NPBC patients were retrospectively reviewed. There were 988 patients with unilateral NPBC (UniNPBC), and 87 patients with ipsilateral NPBC + any contralateral BC [(N + AnyContra) PBC], including 32 patients with bilateral NPBC (BiNPBC) and 55 patients with ipsilateral NPBC + contralateral palpable cancer [(N + Contra) PBC]. Median follow-up time was 91 (48–227) months. Clinicopathological characteristics were compared between UniNPBC and BBC, whereas relapse-free survival (RFS) and overall survival (OS) among BBC subgroups. RFS and OS factors of BBC were identified. RESULTS: Compared to UniNPBC, patients with screen-detected bilateral BC had more invasive (85.1%, 74.8%), ER negative (26.4%, 17.1%), PR negative (36.8%, 23.5%), triple-negative (21.6%, 8.5%) BC as well as less breast conserving surgery (17.2%, 32.4%), radiotherapy (13.8%, 32.0%) and endocrine therapy (71.3%, 83.9%). 10 year RFS and OS rates of (N + AnyContra) PBC (72.8%, 81.5%), (N + Contra) PBC (60.6%, 73.9%), and synchronous (N + Contra) PBC (58.1%, 70.1%) were significantly compromised compared to UniNPBC (91.0%, 97.2%). RFS factors of BBC included pN3 (p = 0.048), lymphovascular invasion (p = 0.008) and existence of contralateral palpable interval BC (p = 0.008), while the OS relevant factor was pN3 (p = 0.018). CONCLUSION: Screen-detected bilateral NPBC including SynBiNPBC and MetaBiNPBC showed good prognosis as UniNPBC so that the therapy of BiNPBC could be de-escalated and optimized according to UniNPBC. Contrarily, screen-detected ipsilateral NPBC with contralateral palpable BC [(N + Contra) PBC] manifested unfavorable survival worse than UniNPBC and synchronous (N + Contra) PBC had the worst survival among all subgroups, implying that these were actually bilateral interval BC and required intensified treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10549-022-06747-5. Springer US 2022-09-27 2022 /pmc/articles/PMC9581860/ /pubmed/36166112 http://dx.doi.org/10.1007/s10549-022-06747-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Epidemiology Pan, Bo Xu, Ying Zhou, Yidong Yao, Ru Zhou, Xingtong Xu, Yali Ren, Xinyu Xiao, Mengsu Zhu, Qingli Kong, Lingyan Mao, Feng Lin, Yan Zhang, Xiaohui Shen, Songjie Sun, Qiang Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003–2017) |
title | Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003–2017) |
title_full | Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003–2017) |
title_fullStr | Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003–2017) |
title_full_unstemmed | Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003–2017) |
title_short | Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003–2017) |
title_sort | long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among chinese women: a hospital-based study (2003–2017) |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581860/ https://www.ncbi.nlm.nih.gov/pubmed/36166112 http://dx.doi.org/10.1007/s10549-022-06747-5 |
work_keys_str_mv | AT panbo longtermsurvivalofscreendetectedsynchronousandmetachronousbilateralnonpalpablebreastcanceramongchinesewomenahospitalbasedstudy20032017 AT xuying longtermsurvivalofscreendetectedsynchronousandmetachronousbilateralnonpalpablebreastcanceramongchinesewomenahospitalbasedstudy20032017 AT zhouyidong longtermsurvivalofscreendetectedsynchronousandmetachronousbilateralnonpalpablebreastcanceramongchinesewomenahospitalbasedstudy20032017 AT yaoru longtermsurvivalofscreendetectedsynchronousandmetachronousbilateralnonpalpablebreastcanceramongchinesewomenahospitalbasedstudy20032017 AT zhouxingtong longtermsurvivalofscreendetectedsynchronousandmetachronousbilateralnonpalpablebreastcanceramongchinesewomenahospitalbasedstudy20032017 AT xuyali longtermsurvivalofscreendetectedsynchronousandmetachronousbilateralnonpalpablebreastcanceramongchinesewomenahospitalbasedstudy20032017 AT renxinyu longtermsurvivalofscreendetectedsynchronousandmetachronousbilateralnonpalpablebreastcanceramongchinesewomenahospitalbasedstudy20032017 AT xiaomengsu longtermsurvivalofscreendetectedsynchronousandmetachronousbilateralnonpalpablebreastcanceramongchinesewomenahospitalbasedstudy20032017 AT zhuqingli longtermsurvivalofscreendetectedsynchronousandmetachronousbilateralnonpalpablebreastcanceramongchinesewomenahospitalbasedstudy20032017 AT konglingyan longtermsurvivalofscreendetectedsynchronousandmetachronousbilateralnonpalpablebreastcanceramongchinesewomenahospitalbasedstudy20032017 AT maofeng longtermsurvivalofscreendetectedsynchronousandmetachronousbilateralnonpalpablebreastcanceramongchinesewomenahospitalbasedstudy20032017 AT linyan longtermsurvivalofscreendetectedsynchronousandmetachronousbilateralnonpalpablebreastcanceramongchinesewomenahospitalbasedstudy20032017 AT zhangxiaohui longtermsurvivalofscreendetectedsynchronousandmetachronousbilateralnonpalpablebreastcanceramongchinesewomenahospitalbasedstudy20032017 AT shensongjie longtermsurvivalofscreendetectedsynchronousandmetachronousbilateralnonpalpablebreastcanceramongchinesewomenahospitalbasedstudy20032017 AT sunqiang longtermsurvivalofscreendetectedsynchronousandmetachronousbilateralnonpalpablebreastcanceramongchinesewomenahospitalbasedstudy20032017 |